Roche to Spread Expertise in Making HIV Drug
January 12, 2006
Pharmaceutical maker Roche Holding AG said today it will offer generic manufacturers in sub-Saharan Africa and the world's least-developed nations the technical expertise to produce versions of saquinavir, a second-line HIV treatment. AIDS activists have been pressing drug companies to offer second-line treatments at reduced prices, following discounts on first-line drugs.
HIV Risk Behaviors and the Context of Sexual Coercion in Young Adults' Sexual Interactions: Results From a Diary Study in Rural South Africa
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.